SlideShare une entreprise Scribd logo
1  sur  45
DRUGS USED IN DISORDERS OF THE
CENTRAL NERVOUS SYSTEM AND
TREATMENT OF PAIN
Lecture 1:
Introduction to the CNS and Drug Action
Marc Imhotep Cray, M.D.
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
Goal of Presentation:
2
The goal of this presentation is to provides an introduction to
the functional organization of the CNS and its synaptic
transmitters as a basis for understanding the actions of the
neurologic and psychiatric drugs described in subsequent
lectures.
o MedPharm Digital Guidebook: Unit 3-Drugs Used for CNS Disorders
o Companion eNotes: CNS- Central Nervous System Pharmacology
o Textbook Reading: Nicoll RA. Ch. 21 Introduction to the Pharmacology of CNS Drugs.
In: Katzung BG, ed. Basic & Clinical Pharmacology. 12th ed. Pgs. 359-71
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
Classification Schema: CNS AGENTS
Antiepileptics
(Anticonvulsants)
Phenytoin
Carbamazepine
Topiramate
Valproic acid
Ethosuxmide
Gabapentin
Tiagabine
GABAergic
Phenobarbital
Thiopental
Diazepam
Zolpidem
Baclofen
General Anesthetic*
Halothane
Local Anesthetic
Procaine
Glutamate Antagonists
Memantine
Riluzole
Serotonin Agonists &
Antagonists
Sumatriptan
Ergotamine
Buspirone
Ondansetron
Alosetron
Antidepressants
Amitriptyline
Fluoxetine
Nefazodone
Phenelzine
Dopamine Agonists &
Antagonists
Levodopa/carbidopa
Pramipexole
Prochlorperazine
Antipsychotics
Chlorpromazine
Haloperidol
Olanzapine
Lithium
Opioids & Opioid Antagonists
Morphine
Codeine
Pentazocine
Diphenoxylate
Methadone
Naloxone
3See: Most Common Drugs (Classes) with Phonetic Pronunciations
*General anesthetics are included
in CNS, although their MOA is not
mediated by neurotransmitters
Note: A drug may be
classified by the
chemical type of the
active ingredient, its
molecular target or by
the way it is used to
treat a particular
condition (therapeutic
indication). Each drug
can be classified into
one or more drug
classes.
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1Major Neuropsychiatric
Disorders and Classes of
Drugs Used for Treatment
4Modified from Brody’s Human Pharmacology, 2010
(N-methyl-D-aspartate)
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
Methods for Study of CNS Pharmacology
5
 Glass microelectrodes permit intracellular neuronal recording
 The brain slice technique permitted an analysis of physiology and pharmacology of
synapses
 Patch clamp technique permits recording of current through single channels
 Channels can be expressed in cultured cells and currents evoked by their activation
recorded
 Histochemical, immunologic, and radioisotopic methods enable mapping of the
distribution of specific transmitters, their associated enzyme systems, and their receptors
 Molecular cloning has made it possible to determine the precise molecular structure of
receptors and their associated channels
 Finally, mice with mutated genes for specific receptors or enzymes (knockout mice) can
provide important information regarding the physiologic and pharmacologic roles of
these components
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1Organization of the Nervous System
BRAIN & SPINAL CORD CENTRAL
NERVOUS
SYSTEM (CNS)
PERIPHERAL
NERVOUS
SYSTEM (PNS)
AFFERENT
(Sensory)
NERVES
EFFERENT
(Motor)
NERVES
EXTEROCEPTORS INTEROCEPTORS SOMATIC AUTONOMIC
EFFECTOR
ORGANS
SKELETAL
MUSCLES
SMOOTH MUSCLE,
CARDIAC MUSCLES
AND GLANDS
VOLUNTARY
Monosynaptic
INVOLUNTARY
Pre & Post Ganglionic Fiber
The central nervous
system (CNS) consists of
the brain and spinal cord.
The CNS receives and
interprets sensory
information (via peripheral
afferent nerves) and then
initiates appropriate
motor responses (via
peripheral efferent
nerves).
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
Overview
7
The properties of the CNS, like the properties of peripheral organs
(ANS), are mediated by neurochemical transmitters acting at
receptor sites
Thus, at the molecular level, the fundamental mechanism of
action (MOA) of drugs affecting the CNS differ little from MOA of
drugs that act on PNS
However, although neurotransmission in CNS parallels that in ANS,
the CNS utilizes several chemicals (amino acid) and peptides as
transmitters in addition to acetylcholine and norepinephrine
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
Overview (2)
8
As in the ANS, the CNS consists of opposing neurotransmitter
systems
 The major excitatory neurotransmitters are the amino acids
glutamate (Glu) and aspartate (Asp)
 The major inhibitory neurotransmitters are GABA and
glycine (Gly)
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
Overview (3)
9
The etiology of CNS functional disorders is often difficult to
determine
Psychosocial and cultural influences are important in
many disorders
Thus, CNS functional disorders are best treated with a
combination of pharmacotherapy and psychosocial
/cultural interventions
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
Overview (4)
10
 Many CNS disorders are not completely understood and thus, they are
imperfectly treated with current medications
 basic research findings continuously provide promising leads for
new drugs
 More is also being learned about the disorders themselves
For example:
 It is now recognized that clinical depression and clinical anxiety
are biochemically distinct from normally experienced feelings of
sadness or apprehension (respectively)
 Schizophrenia is now known to consist of what are known as
positive and negative symptoms
 Pain is now known to be multifaceted
 Neuronal atrophy is implicated in conditions in which it was not
previously suspected
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
Overview (4)
11
Drugs targeted to CNS disorders, like drugs used for
conditions affecting the PNS but to a much larger extent,
are subject to abuse--sometimes by patients but more
often by non-patients
Such abuse can adversely affect the availability of
these drugs (such as opioids for relief of severe
pain) to patients in need
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
Self-directed learning and review
12
Along with the data provided in UNIT 3 of your MedPharm Digital
Guidebook (DRUGS USED IN DISORDERS OF THE CNS AND Tx OF PAIN) the
following illustration plates in Netter's Illustrated Pharmacology, Updated
Edition (2014) * should serve useful to review for this introduction to CNS
Pharm presentation:
 Development of the Nervous System (NIP 3-1)
 Anatomy of the Nervous System (NIP 3-2)
 Functional Correlations and Visualization of Brain Structures (NIP 3-3)
 Resting Membrane and Action Potentials (NIP 3-4)
 Excitatory and Inhibitory Postsynaptic Potentials (NIP 3-5)
* Hyperlink offline. Student access (MS1 & MS2 Core
Digital Textbooks Thumb Drive)
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
Cell Types in the CNS: Neurons and Glia
13
Wecker L, et al. Brody’s human pharmacology : molecular to clinical 5th ed.
 The CNS is composed of two predominant
cell types, neurons and glia, each of which
has many morphologically and functionally
diverse subclasses
 Glial cells outnumber neurons and contain
many neurotransmitter receptors and
transporters
 There are three types of glial cells:
1. Astrocytes
2. Oligodendrocytes
3. Microglia
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
Glia Cells Function, Astrocytes
14
 Astrocytes physically separate neurons and multineuronal
pathways, assist in repairing nerve injury, and modulate the
metabolic and ionic microenvironment
 Astrocytes express ion channels and neurotransmitter
transport proteins and play an active role in modulating
synapse function
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
Glia Cells Function, Oligodendrocytes
15
 Oligodendrocytes form the myelin sheath around axons
and play a critical role in maintaining transmission down
axons
 Polymorphisms (SNP) in the genes encoding several myelin
proteins have been identified in tissues from patients with
both schizophrenia and bipolar disorder and may
contribute to the underlying etiology of these disorders
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
Glia Cells Function, Microglia
16
 Microglia proliferate after injury or degeneration, move
to sites of injury, and transform into large macrophages
(phagocytes) to remove cellular debris
 These antigen presenting cells (APC) with innate immune
function also appear to play a role in endocrine
development
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
Cell Types in the CNS: Neurons
17
 Neurons are the major cells involved in
intercellular communication because of
their ability to conduct impulses and
transmit information
 They are structurally different from other
cells, with four distinct features:
 Dendrites
 A perikaryon (cell body or soma)
 An axon
 A nerve (or axon) terminal
Wecker L, et al. Brody’s human pharmacology : molecular to clinical 5th ed.
Structural components of nerve cells.
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
CNS Neurotransmitters, Receptors, and
Drug Targets
18
 Many substances within the CNS modulate neurotransmitter (NT) actions
 ACh and norepinephrine (NE), predominant in the PNS, also function
in CNS
 Dopamine and 5-HT (serotonin)-more prominent in the CNS-and
peptides such as endorphins are important in CNS function
 Transduction mechanisms for NT action are similar to those in the PNS:
 Ionotropic types include: voltage-gated ion channels (respond to membrane
potential changes) and ligand-gated ion channels (alter membrane ion permeability
in response to ligands such as neurotransmitters or drugs)
 Metabotropic types include: GPCRs and involve second-messenger pathways
(affect ion channels or biochemical reactions)
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
CNS Neurotransmitters, Receptors, and
Drug Targets (2)
19
Drugs affect various sites along neuronal pathways, including:
 neurotransmitter synthesis, storage, and release;
 receptor activation and inhibition;
 modulation of intrasynaptic neurotransmitter metabolism or
reuptake; and
 direct second-messenger pathway effects
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
Neurotransmitters of the Brain and Disease
20
 Treatable neurotransmission diseases fall into two
categories:
 those caused by too much neurotransmission and
 those caused by too little neurotransmission
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
“Too much” neurotransmission
21
May be due to:
A focus of hyperexcitable neurons that fire in the absence of
appropriate stimuli (e.g., seizure disorders)
 Therapy is directed toward reducing automaticity of these
cells
Too many neurotransmitter molecules binding to postsynaptic
receptors (possible explanation for psychoses)
 Therapy includes administration of antagonists which block
postsynaptic receptors
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
“Too little” neurotransmission
22
May be due to:
 Too few neurotransmitter molecules binding to postsynaptic
receptors (e.g., depression, Parkinson's disease)
 Several treatment strategies increase neurotransmission,
including:
1) drugs that cause release of NT stores from presynaptic terminal,
2) neurotransmitter precursors that are taken-up into presynaptic
neurons and metabolized into active neurotransmitter,
3) drugs which inhibit enzymes that degrade neurotransmitters
4) agonists that act at postsynaptic receptors
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
CNS Drugs and Side Effects
23
 Because numerous pathways in brain use the
same neurotransmitter, manipulating transmission in a
diseased pathway simultaneously affects synapses of
normal neurons
 For this reason, CNS drugs are notorious for causing a
variety of side effects
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1Representative
Neurotransmitters
in the CNS
24Wecker L, et al. Brody’s human pharmacology : molecular to clinical 5th ed.
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
Most Well Studied Neurotransmitters
of the Brain
25
1) Norepinephrine
2) Dopamine
3) 5-Hydroxytryptamine (5-HT, Serotonin)
4) Acetylcholine
5) Gamma-amino butyric acid (GABA)
6) Excitatory Amino Acids (EAA), Glutamate
7) The Endogenous Opioids
8) Other Neuropeptides
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
1) Norepinephrine
26
 As you learned during the study of the PNS, there are four classes of
adrenergic receptors: α1, α2, β1, β2
 Pathways in the brain that utilize NE have not been as clearly
identified as in the PNS
 A leading hypothesis suggests depression is caused by impaired
monoamine (e.g., norepinephrine, dopamine, serotonin)
neurotransmission
 Drugs which induce monoamine release are indicated for attention
Deficit Hyperactivity disorder (ADHD) and narcolepsy
 However, the biochemical disturbance responsible for these two
diseases is still not well understood and under ongoing
investigation
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
2) Dopamine
27
 Dopamine is synthesized from Dopa, the
hydroxylated congener of the amino acid
tyrosine
 It is degraded by monoamine oxidase A in
the brain and monoamine oxidase B and
catechol-o-methyl transferase (COMT)
outside the CNS
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
Dopamine (2)
28
Dopamine (DA) receptors are classified as D1 & D2
 Both subtypes reside in numerous regions of the brain
No specific D1 agonists have been identified
Activation of either subtype inhibits the rate of neuronal
firing
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
Dopamine (3)
29
 In the CNS, dopamine serves as a neuromodulator
 Two groupings can be distinguished:
 the family of D1-like receptors (comprising subtypes D1 and D5) and
 the family of D2-like receptors (comprising subtypes D2, D3, and D4)
 Subtypes differ in their signal transduction pathways
 For example, synthesis of cAMP is stimulated by D1-like
receptors but inhibited by D2-like receptors
 Released DA can be reutilized by neuronal reuptake and re-
storage in vesicles or can be catabolized like other
endogenous catecholamines by the enzymes MAO and COMT
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
Dopamine (4)
30
Particularly important dopaminergic pathways include:
1) the nigrostriatal pathway (from substantia nigra to
striatum)
2) neurons of the chemoreceptor trigger zone (CTZ) of the
medulla, which controls vomiting, and
 E.g., Apomorphine is a D2 agonist=emesis-inducing
3) projections from the hypothalamus to the intermediate
lobe of the anterior pituitary, which regulate prolactin
release
 In other words PIF is mediated via DAergic neurons
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
Dopamine (5)
31
 Antipsychotic drugs inhibit dopamine-stimulated adenylate cyclase
(usually associated with D1 receptor activation) and block D2
dopamine receptors
 suggest psychoses may result from overstimulation of dopamine
receptors
 Parkinson's Disease, is caused by too little dopaminergic input from
the substantia nigra into the striatum
 Loss of the nigrostriatal dopamine neurons results in a relative
decrease in dopamine input (inhibitory) compared to
acetylcholine input (excitatory)
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
3) 5-Hydroxytryptamine (5-HT, Serotonin)
32
 The amino acid tryptophan is hydroxylated and
then decarboxylated to form 5-HT
 In neurons, 5-HT is stored (in vesicles), released,
taken up into presynaptic neurons and either
recycled or metabolized
 5-HT is released from inhibitory neurons
originating in the raphe nuclei of the pons and
midbrain
 5-HT stimulates either 5-HT1 or 5-HT2 receptors
which are distinguished by specific antagonists
 methysergide (5-HT1-specific) and
 ketanserin (5-HT2-specific)
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
Serotonin (2)
33
 The hallucinogenic drug, lysergic acid diethylamide (LSD) is a
potent agonist at both receptor subtype
 In addition to its role as a neurotransmitter, 5-HT increases
small intestine motility and modulates vasodilation
 Ninety percent of the body's 5-HT is stored in
enterochromaffin cells of the small intestine
Clinical correlation:
Carcinoid Syndrome: An unusual manifestation of
carcinoid tumor, a neoplasm of enterochromaffin cells. In
patients whose tumor is not surgically resectable, a
serotonin antagonist may constitute a useful treatment.
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
Serotonin (3)
34
 Depression, attention deficit disorder and headaches
have been attributed to serotonergic imbalances
 Many serotonergic agents have been developed in
the last few years for the treatment of these diseases
N.B. Serotonin is an important neurotransmitter, a local hormone in the gut,
a component of the platelet clotting process, thought to play a role in
migraine headache and several other clinical conditions, including carcinoid
syndrome (previous slide).
More on 5-HT in the ”Histamine, Serotonin, & the Ergot Alkaloids” UNIT
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
Serotonin (4)
35
Excess 5-HT can result from accidental or intentional overdose
of drugs that directly activate serotonin receptors or, more
commonly,
drugs that indirectly enhance serotonin levels
 by inhibiting presynaptic neuronal reuptake of serotonin
 by inhibiting serotonin breakdown by monoamine oxidase
 E.g., selective serotonin reuptake inhibitors,
 nonselective serotonin reuptake inhibitors, and
 MAOIs
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
4) Acetylcholine (Ach)
36
 The synthesis, release and degradation of acetylcholine was learned in
PNS study
 Acetylcholine binds to both muscarinic (AChm ) and nicotinic (AChn )
receptors throughout the brain
(Drugs which mimic or modify acetylcholine neurotransmission were also covered in PNS)
 Cholinergic antagonists are used in the treatment of Parkinson's
disease to correct the imbalance of ACh and DA neurotransmission
created by the degradation of dopaminergic nerves
 Cholinergic or anti-cholinergic drugs are not otherwise used to
treat CNS disorders
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
5) Gamma-amino butyric acid (GABA)
37
GABA is an inhibitory amino acid neurotransmitter of
brain interneurons and other cerebral neurons
The enzyme glutamic acid decarboxylase catalyzes the
synthesis of GABA from glutamate
GABA is stored in presynaptic vesicles and binds to
either GABA-A or GABA-B receptors upon release
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
γ-aminobutyric acid (GABA) (2)
38
 GABA receptors reside on two subunits of a four
subunit receptor complex that surrounds and
regulates a chloride ion channel
 GABA activation of the receptor induces chloride
influx into the neuron>>> this hyperpolarizes the
neuron, making it more difficult to fire when
stimulated by excitatory neurotransmitters
 Benzodiazepines (BDZ) enhance the actions of GABA
at GABA-A receptors, but not GABA-B receptors
 Agents which enhance actions of GABA such as BDZ
and barbiturates are used to Tx anxiety & seizures
and as sedatives or muscle relaxants
The GABA-A receptor depicting the membrane-associated
protein composed of five subunits, the Cl– channel, and relative
location of binding sites for GABA, benzodiazepines, barbiturates,
and picrotoxin. From: Brody’s Human Pharmacology, 2010
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
6) Excitatory Amino Acids (EAA), Glutamate
39
 Glutamate or a structurally-similar chemical is an excitatory
neurotransmitter in many areas of the brain
 Stimulation of EAA receptors increases cation conductance,
leading to depolarization, or stimulates phosphatidyl inositol
turnover
 Glutamate transmission occurs via N-methyl-D-aspartate
(NMDA) receptors
 Memantine, used in the Tx of Alzheimer’s disease,
binds to NMDA receptor channels in a use-dependent
manner and produces a noncompetitive blockade
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
Glutamate (2)
40
 Excitatory amino acids such as glutamate are thought to
be important in learning, memory and other brain
functions
 Glutamate induced excitotoxicity is implicated in the
pathogenesis of Alzheimer's Disease, Huntington's
Disease, stroke, epilepsy and amyotrophic lateral sclerosis
(ALS)
 Riluzole protects neurons from glutamate toxicity in
animals and minimally slows progression of ALS
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
N-Methyl-D-Aspartate (NMDA)
41
 Glutamate is an excitatory neurotransmitter, and NMDA
receptors (NMDAR) are one type of glutamate receptor
 Binding of glutamate to NMDA receptors results in
opening of Ca2+ channels, leading to cellular
depolarization and increased neuronal activity
 Blockade of glutamate at NMDA receptors therefore
results in reduced excitation of neurons in the brain
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
7) The Opioids
42
 Endorphins, enkephalins and dynorphins are endogenous
opiate receptor agonists that are cleaved from a protein
called pro-opiomelanocortin
 Opiate receptors are located along the periaqueductal gray
matter
 Morphine and related drugs act at opiate receptors to
relieve pain
 In times of stress or pain, endogenous peptides act at opiate
receptors
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
8) Other Neuropeptides
43
 In addition to the endogenous opiate peptides, other
peptides function as neurotransmitters e.g.,
 Substance P
 vasoactive intestinal peptide (VIP)
 These agents are generally cleaved from larger peptide
precursors
 They can assume a variety of three dimensional shapes,
making it difficult to assess the chemistry of peptide-receptor
interactions
 For this reason, no chemical agonists (other than morphine) or
antagonists have been identified for peptide receptors
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
THE END
44
Marc Imhotep Cray, M.D.
CNS Pharmacology
Lecture 1
45
Lectures/discussions to follow:
2. Sedative-Hypnotic and Anxiolytic Drugs
3. Antiepileptic Agents
4. Antidepressants
5. Drugs Affecting Bipolar Disorder
6. Antipsychotic Agents
7. Drugs Affecting Movement Disorders and Other Neurodegenerative Disorders
8. CNS Skeletal Muscle Relaxants
9. Analgesics and Anesthetics
Further study (SDL):
Online resource center: Medical Pharmacology Cloud Folder

Contenu connexe

Tendances

Muscarinic agonists and antagonists
Muscarinic agonists and antagonistsMuscarinic agonists and antagonists
Muscarinic agonists and antagonistsBrian Piper
 
Serotonin receptors
Serotonin receptorsSerotonin receptors
Serotonin receptorsFarazaJaved
 
Serotonin and anti serotonin drugs
Serotonin and anti serotonin drugsSerotonin and anti serotonin drugs
Serotonin and anti serotonin drugsNaser Tadvi
 
Adrenergic agonists
Adrenergic agonistsAdrenergic agonists
Adrenergic agonistsLeul Mesfin
 
various approaches to drug discovery
various approaches to drug discoveryvarious approaches to drug discovery
various approaches to drug discoveryaiswarya thomas
 
5-Hydroxytrptamine & it's Antagonist
5-Hydroxytrptamine & it's Antagonist5-Hydroxytrptamine & it's Antagonist
5-Hydroxytrptamine & it's AntagonistShubham Patil
 
Parasympathomimetic drugs
Parasympathomimetic drugs Parasympathomimetic drugs
Parasympathomimetic drugs Dr Pralhad Patki
 
Cholinergic system and drugs
Cholinergic system and drugsCholinergic system and drugs
Cholinergic system and drugsDr Roohana Hasan
 
Drug utilization studies
Drug utilization studiesDrug utilization studies
Drug utilization studiesDr Renju Ravi
 
Seretonin (5HT) and Its Antagonists Pharmacology
Seretonin (5HT) and Its Antagonists PharmacologySeretonin (5HT) and Its Antagonists Pharmacology
Seretonin (5HT) and Its Antagonists PharmacologyPranatiChavan
 
Pharmacotherapy of asthma and copd
Pharmacotherapy of asthma and copdPharmacotherapy of asthma and copd
Pharmacotherapy of asthma and copdLalitaShahgond
 
Glutamate receptors
Glutamate receptorsGlutamate receptors
Glutamate receptorsVibha Manu
 
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.DCNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.DKameshwaran Sugavanam
 
Neurohumoral Transmission in CNS
Neurohumoral Transmission in CNSNeurohumoral Transmission in CNS
Neurohumoral Transmission in CNSRaveena Chauhan
 

Tendances (20)

Muscarinic agonists and antagonists
Muscarinic agonists and antagonistsMuscarinic agonists and antagonists
Muscarinic agonists and antagonists
 
Neurotransmitters in CNS
Neurotransmitters in CNSNeurotransmitters in CNS
Neurotransmitters in CNS
 
Serotonin receptors
Serotonin receptorsSerotonin receptors
Serotonin receptors
 
Drugs that act on CNS
Drugs that act on CNSDrugs that act on CNS
Drugs that act on CNS
 
Pharmacotherapy for hypertension
Pharmacotherapy for hypertension Pharmacotherapy for hypertension
Pharmacotherapy for hypertension
 
Serotonin and anti serotonin drugs
Serotonin and anti serotonin drugsSerotonin and anti serotonin drugs
Serotonin and anti serotonin drugs
 
Adrenergic agonists
Adrenergic agonistsAdrenergic agonists
Adrenergic agonists
 
various approaches to drug discovery
various approaches to drug discoveryvarious approaches to drug discovery
various approaches to drug discovery
 
Pharmacology of drugs used in mania
Pharmacology of drugs used in maniaPharmacology of drugs used in mania
Pharmacology of drugs used in mania
 
5-Hydroxytrptamine & it's Antagonist
5-Hydroxytrptamine & it's Antagonist5-Hydroxytrptamine & it's Antagonist
5-Hydroxytrptamine & it's Antagonist
 
Parasympathomimetic drugs
Parasympathomimetic drugs Parasympathomimetic drugs
Parasympathomimetic drugs
 
Cholinergic system and drugs
Cholinergic system and drugsCholinergic system and drugs
Cholinergic system and drugs
 
Drug utilization studies
Drug utilization studiesDrug utilization studies
Drug utilization studies
 
Seretonin (5HT) and Its Antagonists Pharmacology
Seretonin (5HT) and Its Antagonists PharmacologySeretonin (5HT) and Its Antagonists Pharmacology
Seretonin (5HT) and Its Antagonists Pharmacology
 
Pharmacotherapy of asthma and copd
Pharmacotherapy of asthma and copdPharmacotherapy of asthma and copd
Pharmacotherapy of asthma and copd
 
Glutamate receptors
Glutamate receptorsGlutamate receptors
Glutamate receptors
 
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.DCNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
 
Drug metabolism
Drug metabolism Drug metabolism
Drug metabolism
 
Acetylcholine
AcetylcholineAcetylcholine
Acetylcholine
 
Neurohumoral Transmission in CNS
Neurohumoral Transmission in CNSNeurohumoral Transmission in CNS
Neurohumoral Transmission in CNS
 

En vedette

Catalina cordoba historia inspiradora_ana
Catalina cordoba historia inspiradora_anaCatalina cordoba historia inspiradora_ana
Catalina cordoba historia inspiradora_anaRedvolucionCesarNorte
 
галерея белорусской культуры
галерея белорусской культурыгалерея белорусской культуры
галерея белорусской культурыEzelena
 
Lect. 8 Pain, Narcotic and Non-narcotic Analgesics (Analgesic Antipyretics)
Lect. 8 Pain, Narcotic and Non-narcotic Analgesics (Analgesic Antipyretics)Lect. 8 Pain, Narcotic and Non-narcotic Analgesics (Analgesic Antipyretics)
Lect. 8 Pain, Narcotic and Non-narcotic Analgesics (Analgesic Antipyretics)Imhotep Virtual Medical School
 
Templo Puemar do Amanhecer - Consagracao do Adjunto
Templo Puemar do Amanhecer - Consagracao do AdjuntoTemplo Puemar do Amanhecer - Consagracao do Adjunto
Templo Puemar do Amanhecer - Consagracao do AdjuntoClaudio Chiarotto
 
Templo Puemar do Amanhecer - Novo templo
Templo Puemar do Amanhecer - Novo temploTemplo Puemar do Amanhecer - Novo templo
Templo Puemar do Amanhecer - Novo temploClaudio Chiarotto
 
Grading matrix skill ecosystem pmkvy 2.0 , NSDC - SUNAINA SAMRIDDHI FOUNDATION
Grading matrix skill ecosystem pmkvy 2.0 , NSDC - SUNAINA SAMRIDDHI FOUNDATIONGrading matrix skill ecosystem pmkvy 2.0 , NSDC - SUNAINA SAMRIDDHI FOUNDATION
Grading matrix skill ecosystem pmkvy 2.0 , NSDC - SUNAINA SAMRIDDHI FOUNDATIONSUNAINA SAMRIDDHI FOUNDATION
 
Lect. 3 Seizures Disorders and Anticonvulsants (Antiepileptic Agents)
Lect. 3 Seizures Disorders and Anticonvulsants (Antiepileptic Agents)Lect. 3 Seizures Disorders and Anticonvulsants (Antiepileptic Agents)
Lect. 3 Seizures Disorders and Anticonvulsants (Antiepileptic Agents)Imhotep Virtual Medical School
 
To be or not to be?
To be or not to be?To be or not to be?
To be or not to be?iQSpace
 
Как создать себе имя и репутацию
Как создать себе имя и репутацию Как создать себе имя и репутацию
Как создать себе имя и репутацию iQSpace
 
Sistema arterial abdominal y miembros inferiores
Sistema arterial abdominal y miembros inferioresSistema arterial abdominal y miembros inferiores
Sistema arterial abdominal y miembros inferioresAndrea Vizuete
 

En vedette (20)

Lect. 6 Drugs for Neurodegenerative Diseases
Lect. 6 Drugs for Neurodegenerative DiseasesLect. 6 Drugs for Neurodegenerative Diseases
Lect. 6 Drugs for Neurodegenerative Diseases
 
Lect. 5 Psychoses and Antipsychotic Agents
Lect. 5 Psychoses and Antipsychotic AgentsLect. 5 Psychoses and Antipsychotic Agents
Lect. 5 Psychoses and Antipsychotic Agents
 
Inteligenciaemocional 7
Inteligenciaemocional 7Inteligenciaemocional 7
Inteligenciaemocional 7
 
Catalina cordoba historia inspiradora_ana
Catalina cordoba historia inspiradora_anaCatalina cordoba historia inspiradora_ana
Catalina cordoba historia inspiradora_ana
 
Control prenatal
Control prenatalControl prenatal
Control prenatal
 
галерея белорусской культуры
галерея белорусской культурыгалерея белорусской культуры
галерея белорусской культуры
 
Lect. 8 Pain, Narcotic and Non-narcotic Analgesics (Analgesic Antipyretics)
Lect. 8 Pain, Narcotic and Non-narcotic Analgesics (Analgesic Antipyretics)Lect. 8 Pain, Narcotic and Non-narcotic Analgesics (Analgesic Antipyretics)
Lect. 8 Pain, Narcotic and Non-narcotic Analgesics (Analgesic Antipyretics)
 
Templo Puemar do Amanhecer - Consagracao do Adjunto
Templo Puemar do Amanhecer - Consagracao do AdjuntoTemplo Puemar do Amanhecer - Consagracao do Adjunto
Templo Puemar do Amanhecer - Consagracao do Adjunto
 
Templo Puemar do Amanhecer - Novo templo
Templo Puemar do Amanhecer - Novo temploTemplo Puemar do Amanhecer - Novo templo
Templo Puemar do Amanhecer - Novo templo
 
Grading matrix skill ecosystem pmkvy 2.0 , NSDC - SUNAINA SAMRIDDHI FOUNDATION
Grading matrix skill ecosystem pmkvy 2.0 , NSDC - SUNAINA SAMRIDDHI FOUNDATIONGrading matrix skill ecosystem pmkvy 2.0 , NSDC - SUNAINA SAMRIDDHI FOUNDATION
Grading matrix skill ecosystem pmkvy 2.0 , NSDC - SUNAINA SAMRIDDHI FOUNDATION
 
Lect. 3 Seizures Disorders and Anticonvulsants (Antiepileptic Agents)
Lect. 3 Seizures Disorders and Anticonvulsants (Antiepileptic Agents)Lect. 3 Seizures Disorders and Anticonvulsants (Antiepileptic Agents)
Lect. 3 Seizures Disorders and Anticonvulsants (Antiepileptic Agents)
 
Lect. 7 Local and General Anesthetics
Lect. 7 Local and General AnestheticsLect. 7 Local and General Anesthetics
Lect. 7 Local and General Anesthetics
 
To be or not to be?
To be or not to be?To be or not to be?
To be or not to be?
 
Как создать себе имя и репутацию
Как создать себе имя и репутацию Как создать себе имя и репутацию
Как создать себе имя и репутацию
 
Sistema arterial abdominal y miembros inferiores
Sistema arterial abdominal y miembros inferioresSistema arterial abdominal y miembros inferiores
Sistema arterial abdominal y miembros inferiores
 
Fast moving consumer goods ( FMCG )
Fast moving consumer goods ( FMCG )Fast moving consumer goods ( FMCG )
Fast moving consumer goods ( FMCG )
 
Lect 2 Sedative-Hypnotic and Anxiolytic Drugs
Lect 2 Sedative-Hypnotic and Anxiolytic DrugsLect 2 Sedative-Hypnotic and Anxiolytic Drugs
Lect 2 Sedative-Hypnotic and Anxiolytic Drugs
 
Lect. 9 Brain Reward Circuit and Drugs of Abuse
Lect. 9 Brain Reward Circuit and Drugs of AbuseLect. 9 Brain Reward Circuit and Drugs of Abuse
Lect. 9 Brain Reward Circuit and Drugs of Abuse
 
Lect. 4 Clinical Depression and Antidepressants
Lect. 4 Clinical Depression and AntidepressantsLect. 4 Clinical Depression and Antidepressants
Lect. 4 Clinical Depression and Antidepressants
 
Apendicitis Aguda
Apendicitis AgudaApendicitis Aguda
Apendicitis Aguda
 

Similaire à Lect.1 Introduction to CNS and Drug Action

Hans Jürgen-Current situation and future perspetives of antipsychotics in sch...
Hans Jürgen-Current situation and future perspetives of antipsychotics in sch...Hans Jürgen-Current situation and future perspetives of antipsychotics in sch...
Hans Jürgen-Current situation and future perspetives of antipsychotics in sch...Fundación Ramón Areces
 
Autonomic Nervous System Physiology and Pharmacology_Overview| Review of ANS
Autonomic Nervous System Physiology and Pharmacology_Overview| Review of  ANSAutonomic Nervous System Physiology and Pharmacology_Overview| Review of  ANS
Autonomic Nervous System Physiology and Pharmacology_Overview| Review of ANSImhotep Virtual Medical School
 
MAJOR DEPRESSIVE DISORDER
MAJOR DEPRESSIVE DISORDERMAJOR DEPRESSIVE DISORDER
MAJOR DEPRESSIVE DISORDERVln Sekhar
 
ANS Pharmacology -Intro to the Autonomic Nervous System
ANS Pharmacology -Intro to the Autonomic Nervous SystemANS Pharmacology -Intro to the Autonomic Nervous System
ANS Pharmacology -Intro to the Autonomic Nervous SystemImhotep Virtual Medical School
 
Translational Neuroscience Approach in psychiatry..pptx
Translational Neuroscience Approach in psychiatry..pptxTranslational Neuroscience Approach in psychiatry..pptx
Translational Neuroscience Approach in psychiatry..pptxkrishray616
 
Are chemokines the third major system in the brain 1204.full
Are chemokines the third major system in the brain 1204.fullAre chemokines the third major system in the brain 1204.full
Are chemokines the third major system in the brain 1204.fullElsa von Licy
 
The five major divisions of the brain are the telencephalon, the.docx
The five major divisions of the brain are the telencephalon, the.docxThe five major divisions of the brain are the telencephalon, the.docx
The five major divisions of the brain are the telencephalon, the.docxcherry686017
 
Hanipsych, circuits in psych
Hanipsych, circuits in psychHanipsych, circuits in psych
Hanipsych, circuits in psychHani Hamed
 
Chem Imbalance (For)
Chem Imbalance (For)Chem Imbalance (For)
Chem Imbalance (For)psych493
 
fundamentals_of_neurobiology.pptx
fundamentals_of_neurobiology.pptxfundamentals_of_neurobiology.pptx
fundamentals_of_neurobiology.pptxMrHackerxD
 
Targets of Antidepressant Therapy
Targets of Antidepressant TherapyTargets of Antidepressant Therapy
Targets of Antidepressant TherapyAngela Pascuzzi
 
neuroinflammation
neuroinflammationneuroinflammation
neuroinflammationsarvesh022
 
Research article the turing machine theory for some spinal cord and brain con...
Research article the turing machine theory for some spinal cord and brain con...Research article the turing machine theory for some spinal cord and brain con...
Research article the turing machine theory for some spinal cord and brain con...M. Luisetto Pharm.D.Spec. Pharmacology
 
Autonomic Nervous System Physiology and Pharmacology_Overview| Review of ANS
Autonomic Nervous System Physiology and Pharmacology_Overview| Review of ANSAutonomic Nervous System Physiology and Pharmacology_Overview| Review of ANS
Autonomic Nervous System Physiology and Pharmacology_Overview| Review of ANSImhotep Virtual Medical School
 
The autonomic nervous system
The autonomic nervous systemThe autonomic nervous system
The autonomic nervous systemcristiancbg
 

Similaire à Lect.1 Introduction to CNS and Drug Action (20)

Jnnt 3-016-1
Jnnt 3-016-1Jnnt 3-016-1
Jnnt 3-016-1
 
Hans Jürgen-Current situation and future perspetives of antipsychotics in sch...
Hans Jürgen-Current situation and future perspetives of antipsychotics in sch...Hans Jürgen-Current situation and future perspetives of antipsychotics in sch...
Hans Jürgen-Current situation and future perspetives of antipsychotics in sch...
 
Autonomic Nervous System Physiology and Pharmacology_Overview| Review of ANS
Autonomic Nervous System Physiology and Pharmacology_Overview| Review of  ANSAutonomic Nervous System Physiology and Pharmacology_Overview| Review of  ANS
Autonomic Nervous System Physiology and Pharmacology_Overview| Review of ANS
 
MAJOR DEPRESSIVE DISORDER
MAJOR DEPRESSIVE DISORDERMAJOR DEPRESSIVE DISORDER
MAJOR DEPRESSIVE DISORDER
 
ANS Pharmacology -Intro to the Autonomic Nervous System
ANS Pharmacology -Intro to the Autonomic Nervous SystemANS Pharmacology -Intro to the Autonomic Nervous System
ANS Pharmacology -Intro to the Autonomic Nervous System
 
Translational Neuroscience Approach in psychiatry..pptx
Translational Neuroscience Approach in psychiatry..pptxTranslational Neuroscience Approach in psychiatry..pptx
Translational Neuroscience Approach in psychiatry..pptx
 
Are chemokines the third major system in the brain 1204.full
Are chemokines the third major system in the brain 1204.fullAre chemokines the third major system in the brain 1204.full
Are chemokines the third major system in the brain 1204.full
 
The five major divisions of the brain are the telencephalon, the.docx
The five major divisions of the brain are the telencephalon, the.docxThe five major divisions of the brain are the telencephalon, the.docx
The five major divisions of the brain are the telencephalon, the.docx
 
Hanipsych, circuits in psych
Hanipsych, circuits in psychHanipsych, circuits in psych
Hanipsych, circuits in psych
 
Chem Imbalance (For)
Chem Imbalance (For)Chem Imbalance (For)
Chem Imbalance (For)
 
fundamentals_of_neurobiology.pptx
fundamentals_of_neurobiology.pptxfundamentals_of_neurobiology.pptx
fundamentals_of_neurobiology.pptx
 
Targets of Antidepressant Therapy
Targets of Antidepressant TherapyTargets of Antidepressant Therapy
Targets of Antidepressant Therapy
 
Drug Targets
Drug Targets Drug Targets
Drug Targets
 
Nervous system by Dr Chaman Lal (CK)
Nervous system by Dr Chaman Lal (CK)Nervous system by Dr Chaman Lal (CK)
Nervous system by Dr Chaman Lal (CK)
 
neuroinflammation
neuroinflammationneuroinflammation
neuroinflammation
 
Autonomic physiology and pharmacology 1 2017 18 jap
Autonomic physiology and pharmacology 1 2017 18 japAutonomic physiology and pharmacology 1 2017 18 jap
Autonomic physiology and pharmacology 1 2017 18 jap
 
Research article the turing machine theory for some spinal cord and brain con...
Research article the turing machine theory for some spinal cord and brain con...Research article the turing machine theory for some spinal cord and brain con...
Research article the turing machine theory for some spinal cord and brain con...
 
Autonomic Nervous System Physiology and Pharmacology_Overview| Review of ANS
Autonomic Nervous System Physiology and Pharmacology_Overview| Review of ANSAutonomic Nervous System Physiology and Pharmacology_Overview| Review of ANS
Autonomic Nervous System Physiology and Pharmacology_Overview| Review of ANS
 
The autonomic nervous system
The autonomic nervous systemThe autonomic nervous system
The autonomic nervous system
 
Toxicol Sci -2016-Korte CNS admin
Toxicol  Sci -2016-Korte CNS adminToxicol  Sci -2016-Korte CNS admin
Toxicol Sci -2016-Korte CNS admin
 

Plus de Imhotep Virtual Medical School

Oncologic Pathology_A Case-based Organ Systems Review (USMLE Step 1)
Oncologic Pathology_A Case-based Organ Systems Review (USMLE Step 1)Oncologic Pathology_A Case-based Organ Systems Review (USMLE Step 1)
Oncologic Pathology_A Case-based Organ Systems Review (USMLE Step 1)Imhotep Virtual Medical School
 
Reproductive System Pathology_FM Breast and FM Reproductive Systems
Reproductive System Pathology_FM Breast and FM Reproductive SystemsReproductive System Pathology_FM Breast and FM Reproductive Systems
Reproductive System Pathology_FM Breast and FM Reproductive SystemsImhotep Virtual Medical School
 
Reproductive System Pathology_Male Reproductive Systems
Reproductive System Pathology_Male Reproductive SystemsReproductive System Pathology_Male Reproductive Systems
Reproductive System Pathology_Male Reproductive SystemsImhotep Virtual Medical School
 
Nervous System Pathology_A Case-based Learning Approach
Nervous System Pathology_A Case-based Learning ApproachNervous System Pathology_A Case-based Learning Approach
Nervous System Pathology_A Case-based Learning ApproachImhotep Virtual Medical School
 
CVS Function, Regulation of the Heart and Overview of Therapeutic Goals in CV...
CVS Function, Regulation of the Heart and Overview of Therapeutic Goals in CV...CVS Function, Regulation of the Heart and Overview of Therapeutic Goals in CV...
CVS Function, Regulation of the Heart and Overview of Therapeutic Goals in CV...Imhotep Virtual Medical School
 
Cardiovascular Pathology Case-based_Gross and Microscopic
Cardiovascular Pathology Case-based_Gross and MicroscopicCardiovascular Pathology Case-based_Gross and Microscopic
Cardiovascular Pathology Case-based_Gross and MicroscopicImhotep Virtual Medical School
 
Clinical Pharmacology for Medical Students_USMLE Step 1 & 2 Review
Clinical Pharmacology for Medical Students_USMLE Step 1 & 2 ReviewClinical Pharmacology for Medical Students_USMLE Step 1 & 2 Review
Clinical Pharmacology for Medical Students_USMLE Step 1 & 2 ReviewImhotep Virtual Medical School
 
Make the Dx_ A Case-based Intro to Select Cardiovascular and Respiratory Dise...
Make the Dx_ A Case-based Intro to Select Cardiovascular and Respiratory Dise...Make the Dx_ A Case-based Intro to Select Cardiovascular and Respiratory Dise...
Make the Dx_ A Case-based Intro to Select Cardiovascular and Respiratory Dise...Imhotep Virtual Medical School
 
Myocardial infarction_ Causes, Symptoms, Diagnosis, Treatment, and Pathology
Myocardial infarction_ Causes, Symptoms, Diagnosis, Treatment, and PathologyMyocardial infarction_ Causes, Symptoms, Diagnosis, Treatment, and Pathology
Myocardial infarction_ Causes, Symptoms, Diagnosis, Treatment, and PathologyImhotep Virtual Medical School
 
Evidence-Based Physical Diagnosis_Lect. 1_ What is Evidence-Based Physical Di...
Evidence-Based Physical Diagnosis_Lect. 1_ What is Evidence-Based Physical Di...Evidence-Based Physical Diagnosis_Lect. 1_ What is Evidence-Based Physical Di...
Evidence-Based Physical Diagnosis_Lect. 1_ What is Evidence-Based Physical Di...Imhotep Virtual Medical School
 

Plus de Imhotep Virtual Medical School (20)

Oncologic Pathology_A Case-based Organ Systems Review (USMLE Step 1)
Oncologic Pathology_A Case-based Organ Systems Review (USMLE Step 1)Oncologic Pathology_A Case-based Organ Systems Review (USMLE Step 1)
Oncologic Pathology_A Case-based Organ Systems Review (USMLE Step 1)
 
Pathology and Pathophysiology of Shock
Pathology and Pathophysiology of ShockPathology and Pathophysiology of Shock
Pathology and Pathophysiology of Shock
 
Drugs Used In Disorders of the Reproductive System
Drugs Used In Disorders of the Reproductive SystemDrugs Used In Disorders of the Reproductive System
Drugs Used In Disorders of the Reproductive System
 
Reproductive System Pathology_FM Breast and FM Reproductive Systems
Reproductive System Pathology_FM Breast and FM Reproductive SystemsReproductive System Pathology_FM Breast and FM Reproductive Systems
Reproductive System Pathology_FM Breast and FM Reproductive Systems
 
Reproductive System Pathology_Male Reproductive Systems
Reproductive System Pathology_Male Reproductive SystemsReproductive System Pathology_Male Reproductive Systems
Reproductive System Pathology_Male Reproductive Systems
 
Nervous System Pathology_A Case-based Learning Approach
Nervous System Pathology_A Case-based Learning ApproachNervous System Pathology_A Case-based Learning Approach
Nervous System Pathology_A Case-based Learning Approach
 
CVS Function, Regulation of the Heart and Overview of Therapeutic Goals in CV...
CVS Function, Regulation of the Heart and Overview of Therapeutic Goals in CV...CVS Function, Regulation of the Heart and Overview of Therapeutic Goals in CV...
CVS Function, Regulation of the Heart and Overview of Therapeutic Goals in CV...
 
Cardiovascular Pathology Case-based_Gross and Microscopic
Cardiovascular Pathology Case-based_Gross and MicroscopicCardiovascular Pathology Case-based_Gross and Microscopic
Cardiovascular Pathology Case-based_Gross and Microscopic
 
HIV / AIDS Pathology
HIV / AIDS PathologyHIV / AIDS Pathology
HIV / AIDS Pathology
 
Sepsis & Septic Shock
Sepsis & Septic ShockSepsis & Septic Shock
Sepsis & Septic Shock
 
Drugs Used in infectious Disease_Antibiotics
Drugs Used in infectious Disease_AntibioticsDrugs Used in infectious Disease_Antibiotics
Drugs Used in infectious Disease_Antibiotics
 
Hematopoietic and Lymphoid Systems Pathology
Hematopoietic and Lymphoid Systems  PathologyHematopoietic and Lymphoid Systems  Pathology
Hematopoietic and Lymphoid Systems Pathology
 
Drugs Used in Neoplastic Disorders
Drugs Used in Neoplastic DisordersDrugs Used in Neoplastic Disorders
Drugs Used in Neoplastic Disorders
 
Neoplasia & Oncologic Pathology
Neoplasia & Oncologic PathologyNeoplasia & Oncologic Pathology
Neoplasia & Oncologic Pathology
 
Clinical Pharmacology for Medical Students_USMLE Step 1 & 2 Review
Clinical Pharmacology for Medical Students_USMLE Step 1 & 2 ReviewClinical Pharmacology for Medical Students_USMLE Step 1 & 2 Review
Clinical Pharmacology for Medical Students_USMLE Step 1 & 2 Review
 
Make the Dx_ A Case-based Intro to Select Cardiovascular and Respiratory Dise...
Make the Dx_ A Case-based Intro to Select Cardiovascular and Respiratory Dise...Make the Dx_ A Case-based Intro to Select Cardiovascular and Respiratory Dise...
Make the Dx_ A Case-based Intro to Select Cardiovascular and Respiratory Dise...
 
Myocardial infarction_ Causes, Symptoms, Diagnosis, Treatment, and Pathology
Myocardial infarction_ Causes, Symptoms, Diagnosis, Treatment, and PathologyMyocardial infarction_ Causes, Symptoms, Diagnosis, Treatment, and Pathology
Myocardial infarction_ Causes, Symptoms, Diagnosis, Treatment, and Pathology
 
Basic CXR Interpretation_Diagnostic Radiographs
Basic CXR Interpretation_Diagnostic RadiographsBasic CXR Interpretation_Diagnostic Radiographs
Basic CXR Interpretation_Diagnostic Radiographs
 
Electrocardiogram (ECG) Interpretation_Module 1 of 2
Electrocardiogram (ECG) Interpretation_Module 1 of 2Electrocardiogram (ECG) Interpretation_Module 1 of 2
Electrocardiogram (ECG) Interpretation_Module 1 of 2
 
Evidence-Based Physical Diagnosis_Lect. 1_ What is Evidence-Based Physical Di...
Evidence-Based Physical Diagnosis_Lect. 1_ What is Evidence-Based Physical Di...Evidence-Based Physical Diagnosis_Lect. 1_ What is Evidence-Based Physical Di...
Evidence-Based Physical Diagnosis_Lect. 1_ What is Evidence-Based Physical Di...
 

Dernier

Practical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptxPractical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptxKatherine Villaluna
 
The basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptxThe basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptxheathfieldcps1
 
Philosophy of Education and Educational Philosophy
Philosophy of Education  and Educational PhilosophyPhilosophy of Education  and Educational Philosophy
Philosophy of Education and Educational PhilosophyShuvankar Madhu
 
How to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 SalesHow to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 SalesCeline George
 
In - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxIn - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxAditiChauhan701637
 
The Singapore Teaching Practice document
The Singapore Teaching Practice documentThe Singapore Teaching Practice document
The Singapore Teaching Practice documentXsasf Sfdfasd
 
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfP4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfYu Kanazawa / Osaka University
 
Presentation on the Basics of Writing. Writing a Paragraph
Presentation on the Basics of Writing. Writing a ParagraphPresentation on the Basics of Writing. Writing a Paragraph
Presentation on the Basics of Writing. Writing a ParagraphNetziValdelomar1
 
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRADUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRATanmoy Mishra
 
HED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdfHED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdfMohonDas
 
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxAUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxiammrhaywood
 
How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17Celine George
 
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdfMaximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdfTechSoup
 
How to Use api.constrains ( ) in Odoo 17
How to Use api.constrains ( ) in Odoo 17How to Use api.constrains ( ) in Odoo 17
How to Use api.constrains ( ) in Odoo 17Celine George
 
What is the Future of QuickBooks DeskTop?
What is the Future of QuickBooks DeskTop?What is the Future of QuickBooks DeskTop?
What is the Future of QuickBooks DeskTop?TechSoup
 
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptxraviapr7
 
The Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsThe Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsEugene Lysak
 
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptxSandy Millin
 

Dernier (20)

Practical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptxPractical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptx
 
The basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptxThe basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptx
 
Philosophy of Education and Educational Philosophy
Philosophy of Education  and Educational PhilosophyPhilosophy of Education  and Educational Philosophy
Philosophy of Education and Educational Philosophy
 
How to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 SalesHow to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 Sales
 
In - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxIn - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptx
 
The Singapore Teaching Practice document
The Singapore Teaching Practice documentThe Singapore Teaching Practice document
The Singapore Teaching Practice document
 
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfP4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
 
Prelims of Kant get Marx 2.0: a general politics quiz
Prelims of Kant get Marx 2.0: a general politics quizPrelims of Kant get Marx 2.0: a general politics quiz
Prelims of Kant get Marx 2.0: a general politics quiz
 
Presentation on the Basics of Writing. Writing a Paragraph
Presentation on the Basics of Writing. Writing a ParagraphPresentation on the Basics of Writing. Writing a Paragraph
Presentation on the Basics of Writing. Writing a Paragraph
 
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRADUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
 
HED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdfHED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdf
 
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxAUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
 
Finals of Kant get Marx 2.0 : a general politics quiz
Finals of Kant get Marx 2.0 : a general politics quizFinals of Kant get Marx 2.0 : a general politics quiz
Finals of Kant get Marx 2.0 : a general politics quiz
 
How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17How to Add a New Field in Existing Kanban View in Odoo 17
How to Add a New Field in Existing Kanban View in Odoo 17
 
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdfMaximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
 
How to Use api.constrains ( ) in Odoo 17
How to Use api.constrains ( ) in Odoo 17How to Use api.constrains ( ) in Odoo 17
How to Use api.constrains ( ) in Odoo 17
 
What is the Future of QuickBooks DeskTop?
What is the Future of QuickBooks DeskTop?What is the Future of QuickBooks DeskTop?
What is the Future of QuickBooks DeskTop?
 
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
 
The Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsThe Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George Wells
 
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
 

Lect.1 Introduction to CNS and Drug Action

  • 1. DRUGS USED IN DISORDERS OF THE CENTRAL NERVOUS SYSTEM AND TREATMENT OF PAIN Lecture 1: Introduction to the CNS and Drug Action Marc Imhotep Cray, M.D.
  • 2. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 Goal of Presentation: 2 The goal of this presentation is to provides an introduction to the functional organization of the CNS and its synaptic transmitters as a basis for understanding the actions of the neurologic and psychiatric drugs described in subsequent lectures. o MedPharm Digital Guidebook: Unit 3-Drugs Used for CNS Disorders o Companion eNotes: CNS- Central Nervous System Pharmacology o Textbook Reading: Nicoll RA. Ch. 21 Introduction to the Pharmacology of CNS Drugs. In: Katzung BG, ed. Basic & Clinical Pharmacology. 12th ed. Pgs. 359-71
  • 3. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 Classification Schema: CNS AGENTS Antiepileptics (Anticonvulsants) Phenytoin Carbamazepine Topiramate Valproic acid Ethosuxmide Gabapentin Tiagabine GABAergic Phenobarbital Thiopental Diazepam Zolpidem Baclofen General Anesthetic* Halothane Local Anesthetic Procaine Glutamate Antagonists Memantine Riluzole Serotonin Agonists & Antagonists Sumatriptan Ergotamine Buspirone Ondansetron Alosetron Antidepressants Amitriptyline Fluoxetine Nefazodone Phenelzine Dopamine Agonists & Antagonists Levodopa/carbidopa Pramipexole Prochlorperazine Antipsychotics Chlorpromazine Haloperidol Olanzapine Lithium Opioids & Opioid Antagonists Morphine Codeine Pentazocine Diphenoxylate Methadone Naloxone 3See: Most Common Drugs (Classes) with Phonetic Pronunciations *General anesthetics are included in CNS, although their MOA is not mediated by neurotransmitters Note: A drug may be classified by the chemical type of the active ingredient, its molecular target or by the way it is used to treat a particular condition (therapeutic indication). Each drug can be classified into one or more drug classes.
  • 4. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1Major Neuropsychiatric Disorders and Classes of Drugs Used for Treatment 4Modified from Brody’s Human Pharmacology, 2010 (N-methyl-D-aspartate)
  • 5. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 Methods for Study of CNS Pharmacology 5  Glass microelectrodes permit intracellular neuronal recording  The brain slice technique permitted an analysis of physiology and pharmacology of synapses  Patch clamp technique permits recording of current through single channels  Channels can be expressed in cultured cells and currents evoked by their activation recorded  Histochemical, immunologic, and radioisotopic methods enable mapping of the distribution of specific transmitters, their associated enzyme systems, and their receptors  Molecular cloning has made it possible to determine the precise molecular structure of receptors and their associated channels  Finally, mice with mutated genes for specific receptors or enzymes (knockout mice) can provide important information regarding the physiologic and pharmacologic roles of these components
  • 6. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1Organization of the Nervous System BRAIN & SPINAL CORD CENTRAL NERVOUS SYSTEM (CNS) PERIPHERAL NERVOUS SYSTEM (PNS) AFFERENT (Sensory) NERVES EFFERENT (Motor) NERVES EXTEROCEPTORS INTEROCEPTORS SOMATIC AUTONOMIC EFFECTOR ORGANS SKELETAL MUSCLES SMOOTH MUSCLE, CARDIAC MUSCLES AND GLANDS VOLUNTARY Monosynaptic INVOLUNTARY Pre & Post Ganglionic Fiber The central nervous system (CNS) consists of the brain and spinal cord. The CNS receives and interprets sensory information (via peripheral afferent nerves) and then initiates appropriate motor responses (via peripheral efferent nerves).
  • 7. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 Overview 7 The properties of the CNS, like the properties of peripheral organs (ANS), are mediated by neurochemical transmitters acting at receptor sites Thus, at the molecular level, the fundamental mechanism of action (MOA) of drugs affecting the CNS differ little from MOA of drugs that act on PNS However, although neurotransmission in CNS parallels that in ANS, the CNS utilizes several chemicals (amino acid) and peptides as transmitters in addition to acetylcholine and norepinephrine
  • 8. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 Overview (2) 8 As in the ANS, the CNS consists of opposing neurotransmitter systems  The major excitatory neurotransmitters are the amino acids glutamate (Glu) and aspartate (Asp)  The major inhibitory neurotransmitters are GABA and glycine (Gly)
  • 9. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 Overview (3) 9 The etiology of CNS functional disorders is often difficult to determine Psychosocial and cultural influences are important in many disorders Thus, CNS functional disorders are best treated with a combination of pharmacotherapy and psychosocial /cultural interventions
  • 10. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 Overview (4) 10  Many CNS disorders are not completely understood and thus, they are imperfectly treated with current medications  basic research findings continuously provide promising leads for new drugs  More is also being learned about the disorders themselves For example:  It is now recognized that clinical depression and clinical anxiety are biochemically distinct from normally experienced feelings of sadness or apprehension (respectively)  Schizophrenia is now known to consist of what are known as positive and negative symptoms  Pain is now known to be multifaceted  Neuronal atrophy is implicated in conditions in which it was not previously suspected
  • 11. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 Overview (4) 11 Drugs targeted to CNS disorders, like drugs used for conditions affecting the PNS but to a much larger extent, are subject to abuse--sometimes by patients but more often by non-patients Such abuse can adversely affect the availability of these drugs (such as opioids for relief of severe pain) to patients in need
  • 12. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 Self-directed learning and review 12 Along with the data provided in UNIT 3 of your MedPharm Digital Guidebook (DRUGS USED IN DISORDERS OF THE CNS AND Tx OF PAIN) the following illustration plates in Netter's Illustrated Pharmacology, Updated Edition (2014) * should serve useful to review for this introduction to CNS Pharm presentation:  Development of the Nervous System (NIP 3-1)  Anatomy of the Nervous System (NIP 3-2)  Functional Correlations and Visualization of Brain Structures (NIP 3-3)  Resting Membrane and Action Potentials (NIP 3-4)  Excitatory and Inhibitory Postsynaptic Potentials (NIP 3-5) * Hyperlink offline. Student access (MS1 & MS2 Core Digital Textbooks Thumb Drive)
  • 13. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 Cell Types in the CNS: Neurons and Glia 13 Wecker L, et al. Brody’s human pharmacology : molecular to clinical 5th ed.  The CNS is composed of two predominant cell types, neurons and glia, each of which has many morphologically and functionally diverse subclasses  Glial cells outnumber neurons and contain many neurotransmitter receptors and transporters  There are three types of glial cells: 1. Astrocytes 2. Oligodendrocytes 3. Microglia
  • 14. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 Glia Cells Function, Astrocytes 14  Astrocytes physically separate neurons and multineuronal pathways, assist in repairing nerve injury, and modulate the metabolic and ionic microenvironment  Astrocytes express ion channels and neurotransmitter transport proteins and play an active role in modulating synapse function
  • 15. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 Glia Cells Function, Oligodendrocytes 15  Oligodendrocytes form the myelin sheath around axons and play a critical role in maintaining transmission down axons  Polymorphisms (SNP) in the genes encoding several myelin proteins have been identified in tissues from patients with both schizophrenia and bipolar disorder and may contribute to the underlying etiology of these disorders
  • 16. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 Glia Cells Function, Microglia 16  Microglia proliferate after injury or degeneration, move to sites of injury, and transform into large macrophages (phagocytes) to remove cellular debris  These antigen presenting cells (APC) with innate immune function also appear to play a role in endocrine development
  • 17. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 Cell Types in the CNS: Neurons 17  Neurons are the major cells involved in intercellular communication because of their ability to conduct impulses and transmit information  They are structurally different from other cells, with four distinct features:  Dendrites  A perikaryon (cell body or soma)  An axon  A nerve (or axon) terminal Wecker L, et al. Brody’s human pharmacology : molecular to clinical 5th ed. Structural components of nerve cells.
  • 18. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 CNS Neurotransmitters, Receptors, and Drug Targets 18  Many substances within the CNS modulate neurotransmitter (NT) actions  ACh and norepinephrine (NE), predominant in the PNS, also function in CNS  Dopamine and 5-HT (serotonin)-more prominent in the CNS-and peptides such as endorphins are important in CNS function  Transduction mechanisms for NT action are similar to those in the PNS:  Ionotropic types include: voltage-gated ion channels (respond to membrane potential changes) and ligand-gated ion channels (alter membrane ion permeability in response to ligands such as neurotransmitters or drugs)  Metabotropic types include: GPCRs and involve second-messenger pathways (affect ion channels or biochemical reactions)
  • 19. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 CNS Neurotransmitters, Receptors, and Drug Targets (2) 19 Drugs affect various sites along neuronal pathways, including:  neurotransmitter synthesis, storage, and release;  receptor activation and inhibition;  modulation of intrasynaptic neurotransmitter metabolism or reuptake; and  direct second-messenger pathway effects
  • 20. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 Neurotransmitters of the Brain and Disease 20  Treatable neurotransmission diseases fall into two categories:  those caused by too much neurotransmission and  those caused by too little neurotransmission
  • 21. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 “Too much” neurotransmission 21 May be due to: A focus of hyperexcitable neurons that fire in the absence of appropriate stimuli (e.g., seizure disorders)  Therapy is directed toward reducing automaticity of these cells Too many neurotransmitter molecules binding to postsynaptic receptors (possible explanation for psychoses)  Therapy includes administration of antagonists which block postsynaptic receptors
  • 22. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 “Too little” neurotransmission 22 May be due to:  Too few neurotransmitter molecules binding to postsynaptic receptors (e.g., depression, Parkinson's disease)  Several treatment strategies increase neurotransmission, including: 1) drugs that cause release of NT stores from presynaptic terminal, 2) neurotransmitter precursors that are taken-up into presynaptic neurons and metabolized into active neurotransmitter, 3) drugs which inhibit enzymes that degrade neurotransmitters 4) agonists that act at postsynaptic receptors
  • 23. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 CNS Drugs and Side Effects 23  Because numerous pathways in brain use the same neurotransmitter, manipulating transmission in a diseased pathway simultaneously affects synapses of normal neurons  For this reason, CNS drugs are notorious for causing a variety of side effects
  • 24. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1Representative Neurotransmitters in the CNS 24Wecker L, et al. Brody’s human pharmacology : molecular to clinical 5th ed.
  • 25. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 Most Well Studied Neurotransmitters of the Brain 25 1) Norepinephrine 2) Dopamine 3) 5-Hydroxytryptamine (5-HT, Serotonin) 4) Acetylcholine 5) Gamma-amino butyric acid (GABA) 6) Excitatory Amino Acids (EAA), Glutamate 7) The Endogenous Opioids 8) Other Neuropeptides
  • 26. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 1) Norepinephrine 26  As you learned during the study of the PNS, there are four classes of adrenergic receptors: α1, α2, β1, β2  Pathways in the brain that utilize NE have not been as clearly identified as in the PNS  A leading hypothesis suggests depression is caused by impaired monoamine (e.g., norepinephrine, dopamine, serotonin) neurotransmission  Drugs which induce monoamine release are indicated for attention Deficit Hyperactivity disorder (ADHD) and narcolepsy  However, the biochemical disturbance responsible for these two diseases is still not well understood and under ongoing investigation
  • 27. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 2) Dopamine 27  Dopamine is synthesized from Dopa, the hydroxylated congener of the amino acid tyrosine  It is degraded by monoamine oxidase A in the brain and monoamine oxidase B and catechol-o-methyl transferase (COMT) outside the CNS
  • 28. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 Dopamine (2) 28 Dopamine (DA) receptors are classified as D1 & D2  Both subtypes reside in numerous regions of the brain No specific D1 agonists have been identified Activation of either subtype inhibits the rate of neuronal firing
  • 29. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 Dopamine (3) 29  In the CNS, dopamine serves as a neuromodulator  Two groupings can be distinguished:  the family of D1-like receptors (comprising subtypes D1 and D5) and  the family of D2-like receptors (comprising subtypes D2, D3, and D4)  Subtypes differ in their signal transduction pathways  For example, synthesis of cAMP is stimulated by D1-like receptors but inhibited by D2-like receptors  Released DA can be reutilized by neuronal reuptake and re- storage in vesicles or can be catabolized like other endogenous catecholamines by the enzymes MAO and COMT
  • 30. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 Dopamine (4) 30 Particularly important dopaminergic pathways include: 1) the nigrostriatal pathway (from substantia nigra to striatum) 2) neurons of the chemoreceptor trigger zone (CTZ) of the medulla, which controls vomiting, and  E.g., Apomorphine is a D2 agonist=emesis-inducing 3) projections from the hypothalamus to the intermediate lobe of the anterior pituitary, which regulate prolactin release  In other words PIF is mediated via DAergic neurons
  • 31. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 Dopamine (5) 31  Antipsychotic drugs inhibit dopamine-stimulated adenylate cyclase (usually associated with D1 receptor activation) and block D2 dopamine receptors  suggest psychoses may result from overstimulation of dopamine receptors  Parkinson's Disease, is caused by too little dopaminergic input from the substantia nigra into the striatum  Loss of the nigrostriatal dopamine neurons results in a relative decrease in dopamine input (inhibitory) compared to acetylcholine input (excitatory)
  • 32. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 3) 5-Hydroxytryptamine (5-HT, Serotonin) 32  The amino acid tryptophan is hydroxylated and then decarboxylated to form 5-HT  In neurons, 5-HT is stored (in vesicles), released, taken up into presynaptic neurons and either recycled or metabolized  5-HT is released from inhibitory neurons originating in the raphe nuclei of the pons and midbrain  5-HT stimulates either 5-HT1 or 5-HT2 receptors which are distinguished by specific antagonists  methysergide (5-HT1-specific) and  ketanserin (5-HT2-specific)
  • 33. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 Serotonin (2) 33  The hallucinogenic drug, lysergic acid diethylamide (LSD) is a potent agonist at both receptor subtype  In addition to its role as a neurotransmitter, 5-HT increases small intestine motility and modulates vasodilation  Ninety percent of the body's 5-HT is stored in enterochromaffin cells of the small intestine Clinical correlation: Carcinoid Syndrome: An unusual manifestation of carcinoid tumor, a neoplasm of enterochromaffin cells. In patients whose tumor is not surgically resectable, a serotonin antagonist may constitute a useful treatment.
  • 34. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 Serotonin (3) 34  Depression, attention deficit disorder and headaches have been attributed to serotonergic imbalances  Many serotonergic agents have been developed in the last few years for the treatment of these diseases N.B. Serotonin is an important neurotransmitter, a local hormone in the gut, a component of the platelet clotting process, thought to play a role in migraine headache and several other clinical conditions, including carcinoid syndrome (previous slide). More on 5-HT in the ”Histamine, Serotonin, & the Ergot Alkaloids” UNIT
  • 35. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 Serotonin (4) 35 Excess 5-HT can result from accidental or intentional overdose of drugs that directly activate serotonin receptors or, more commonly, drugs that indirectly enhance serotonin levels  by inhibiting presynaptic neuronal reuptake of serotonin  by inhibiting serotonin breakdown by monoamine oxidase  E.g., selective serotonin reuptake inhibitors,  nonselective serotonin reuptake inhibitors, and  MAOIs
  • 36. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 4) Acetylcholine (Ach) 36  The synthesis, release and degradation of acetylcholine was learned in PNS study  Acetylcholine binds to both muscarinic (AChm ) and nicotinic (AChn ) receptors throughout the brain (Drugs which mimic or modify acetylcholine neurotransmission were also covered in PNS)  Cholinergic antagonists are used in the treatment of Parkinson's disease to correct the imbalance of ACh and DA neurotransmission created by the degradation of dopaminergic nerves  Cholinergic or anti-cholinergic drugs are not otherwise used to treat CNS disorders
  • 37. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 5) Gamma-amino butyric acid (GABA) 37 GABA is an inhibitory amino acid neurotransmitter of brain interneurons and other cerebral neurons The enzyme glutamic acid decarboxylase catalyzes the synthesis of GABA from glutamate GABA is stored in presynaptic vesicles and binds to either GABA-A or GABA-B receptors upon release
  • 38. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 γ-aminobutyric acid (GABA) (2) 38  GABA receptors reside on two subunits of a four subunit receptor complex that surrounds and regulates a chloride ion channel  GABA activation of the receptor induces chloride influx into the neuron>>> this hyperpolarizes the neuron, making it more difficult to fire when stimulated by excitatory neurotransmitters  Benzodiazepines (BDZ) enhance the actions of GABA at GABA-A receptors, but not GABA-B receptors  Agents which enhance actions of GABA such as BDZ and barbiturates are used to Tx anxiety & seizures and as sedatives or muscle relaxants The GABA-A receptor depicting the membrane-associated protein composed of five subunits, the Cl– channel, and relative location of binding sites for GABA, benzodiazepines, barbiturates, and picrotoxin. From: Brody’s Human Pharmacology, 2010
  • 39. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 6) Excitatory Amino Acids (EAA), Glutamate 39  Glutamate or a structurally-similar chemical is an excitatory neurotransmitter in many areas of the brain  Stimulation of EAA receptors increases cation conductance, leading to depolarization, or stimulates phosphatidyl inositol turnover  Glutamate transmission occurs via N-methyl-D-aspartate (NMDA) receptors  Memantine, used in the Tx of Alzheimer’s disease, binds to NMDA receptor channels in a use-dependent manner and produces a noncompetitive blockade
  • 40. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 Glutamate (2) 40  Excitatory amino acids such as glutamate are thought to be important in learning, memory and other brain functions  Glutamate induced excitotoxicity is implicated in the pathogenesis of Alzheimer's Disease, Huntington's Disease, stroke, epilepsy and amyotrophic lateral sclerosis (ALS)  Riluzole protects neurons from glutamate toxicity in animals and minimally slows progression of ALS
  • 41. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 N-Methyl-D-Aspartate (NMDA) 41  Glutamate is an excitatory neurotransmitter, and NMDA receptors (NMDAR) are one type of glutamate receptor  Binding of glutamate to NMDA receptors results in opening of Ca2+ channels, leading to cellular depolarization and increased neuronal activity  Blockade of glutamate at NMDA receptors therefore results in reduced excitation of neurons in the brain
  • 42. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 7) The Opioids 42  Endorphins, enkephalins and dynorphins are endogenous opiate receptor agonists that are cleaved from a protein called pro-opiomelanocortin  Opiate receptors are located along the periaqueductal gray matter  Morphine and related drugs act at opiate receptors to relieve pain  In times of stress or pain, endogenous peptides act at opiate receptors
  • 43. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 8) Other Neuropeptides 43  In addition to the endogenous opiate peptides, other peptides function as neurotransmitters e.g.,  Substance P  vasoactive intestinal peptide (VIP)  These agents are generally cleaved from larger peptide precursors  They can assume a variety of three dimensional shapes, making it difficult to assess the chemistry of peptide-receptor interactions  For this reason, no chemical agonists (other than morphine) or antagonists have been identified for peptide receptors
  • 44. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 THE END 44
  • 45. Marc Imhotep Cray, M.D. CNS Pharmacology Lecture 1 45 Lectures/discussions to follow: 2. Sedative-Hypnotic and Anxiolytic Drugs 3. Antiepileptic Agents 4. Antidepressants 5. Drugs Affecting Bipolar Disorder 6. Antipsychotic Agents 7. Drugs Affecting Movement Disorders and Other Neurodegenerative Disorders 8. CNS Skeletal Muscle Relaxants 9. Analgesics and Anesthetics Further study (SDL): Online resource center: Medical Pharmacology Cloud Folder